West Pharmaceutical Services, Inc. (WST) — Free Cash Flow Yield
Healthcare
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
| Metric | Value |
|---|---|
| FCF Yield | 1.9% |
| Healthcare Sector Avg FCF Yield | 4.9% |
| Annual Free Cash Flow | $469M |
| Market Cap | $24.6B |
| P/E Ratio | 44.6x |
West Pharmaceutical Services, Inc.'s FCF yield of 1.9% is below the Healthcare sector average (4.9%).
Frequently Asked Questions
What is West Pharmaceutical Services, Inc.'s (WST) free cash flow yield?
West Pharmaceutical Services, Inc.'s (WST) free cash flow yield is 1.9%. That is below the Healthcare sector average (4.9%).
Is WST's free cash flow yield good?
At 1.9%, WST's free cash flow yield is considered weak — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does West Pharmaceutical Services, Inc. generate?
West Pharmaceutical Services, Inc. generated $469M in free cash flow, against a market cap of $24.6B.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →